ARCHIVES

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

NCI says SELECT study is close to full enrollment.

April 23, 2004

In Brief: NCHSR Says Autologous Marrow Transplant Is A “Reasonable Therapeutic Alternative”

August 11, 1989

Funding Opportunities: NIH Creates Awards For Clinical Research

March 27, 1998

DCBDC Board Cool to Proposals On Study Sections

November 23, 1990

Proposed Deal Could Resolve Key Disputes At NSABP, Pitt

January 13, 1995

In Brief: Organ systems Coordinating Center Decision Still Delayed; Branch Merged With DCPC Centers Branch

June 29, 1984